Overview

Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression

Status:
NOT_YET_RECRUITING
Trial end date:
2031-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this multi-site randomized controlled trial is to evaluate the efficacy and risks of psilocybin for the treatment of depression in U.S. military Veterans with and without () concurrent posttraumatic stress disorder.
Phase:
PHASE3
Details
Lead Sponsor:
VA Office of Research and Development
Treatments:
Psilocybin